Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 436 entries
View as:

Study on the Staging and Prognosis Model of Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06565923 Org: User:
Start: 03/18/24 End: 07/18/25 Due: 07/18/26

Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT06253091 Org: User:
Start: 02/01/24 End: 12/30/25 Due: 12/30/26

Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC

Phase: N/A Priority: Normal
NCT ID: NCT05956639 Org: User:
Start: 06/20/23 End: 12/31/27 Due: 12/31/28

Obeservational Cohort for Evaluating Future Cardiovascular Disease With High Metabolic Risks

Phase: N/A Priority: Normal
NCT ID: NCT06385431 Org: User:
Start: 04/28/24 End: 04/30/26 Due: 04/30/27

Atrial Fibrillation With Sinus Node Dysfunction: Intensive Device Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT03607123 Org: User:
Start: 07/04/18 End: 07/04/22 Due: 07/04/23

A Multi-omics Study of "Healthy" Premature CAD Patients

Phase: N/A Priority: Normal
NCT ID: NCT06362278 Org: User:
Start: 03/20/24 End: 12/31/25 Due: 12/31/26

Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04502680 Org: User:
Start: 06/30/21 End: 06/30/24 Due: 06/30/25

The OPTIMA-5 Trail

Phase: N/A Priority: Normal
NCT ID: NCT05023681 Org: User:
Start: 10/29/21 End: 09/14/22 Due: 09/14/23

Internal Limiting Membrane Peeling on Retinal Displacement

Phase: N/A Priority: Normal
NCT ID: NCT04655781 Org: User:
Start: 01/01/17 End: 01/31/18 Due: 01/31/19

High-Risk Factors in Patients With Colorectal Polyps a Prospective Case-Control Study

Phase: N/A Priority: Normal
NCT ID: NCT04684134 Org: User:
Start: 06/01/19 End: 06/01/20 Due: 06/01/21

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06838910 Org: User:
Start: 03/31/25 End: 12/31/26 Due: 12/31/27

Effect of Suanzaoren Decoction and Huanglian Wendan Decoction on Biorhythm of Insomnia Patients

Phase: N/A Priority: Normal
NCT ID: NCT06467851 Org: User:
Start: 08/31/23 End: 04/10/24 Due: 04/10/25

Characteristic Transcriptomic, Proteomic and Metabolomic Molecular Studies of Nasal Secretions From Chronic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT06678334 Org: User:
Start: 11/06/24 End: 12/01/32 Due: 12/01/33

Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT03078257 Org: User:
Start: 01/01/16 End: 12/31/17 Due: 12/31/18

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02882269 Org: User:
Start: 12/31/16 End: 12/31/21 Due: 12/31/22

RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06385873 Org: User:
Start: 05/01/24 End: 05/01/28 Due: 05/01/29

Hypofractionated Radiation Fractionation in Breast Cancer Patients with Implant-Based Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT06830083 Org: User:
Start: 01/30/25 End: 12/31/33 Due: 12/31/34

An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05166070 Org: User:
Start: 01/01/22 End: 01/01/37 Due: 01/01/38

Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot

Phase: N/A Priority: Normal
NCT ID: NCT05999656 Org: User:
Start: 05/28/23 End: 11/28/24 Due: 11/28/25

Insomnia Treated by Traditional Chinese Medicine and Its Circadian Rhythm

Phase: N/A Priority: Normal
NCT ID: NCT04448197 Org: User:
Start: 03/04/20 End: 01/30/21 Due: 01/30/22

Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein

Phase: N/A Priority: Normal
NCT ID: NCT02430207 Org: User:
Start: 05/31/15 End: - Due: -

Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT06052020 Org: User:
Start: 09/15/23 End: 09/30/24 Due: 09/30/25

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06835179 Org: User:
Start: 02/28/25 End: 05/31/27 Due: 05/31/28

Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05291052 Org: User:
Start: 02/14/22 End: 03/30/24 Due: 03/30/25

Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus

Phase: N/A Priority: Normal
NCT ID: NCT03415386 Org: User:
Start: 06/30/20 End: 06/30/22 Due: 06/30/23